Clinical Trials, Research and Development
January 23, 2024
Via: PharmaphorumTesting a person’s blood for a protein called phosphorylated tau could provide a means of large-scale screening for Alzheimer’s disease (AD), according to a new study. The immunoassay – which has been developed by California biotech ALZpath – focuses on […]
October 12, 2023
Via: Pharma TimesAstronauTx has announced the completion of a £48m Series A financing to create new treatments for Alzheimer’s disease (AD). As part of the investment led by the Novartis Venture Fund, the financing was supported by several global venture investors, including […]
July 11, 2024
July 11, 2024
July 19, 2024
Copyright © 2024. All rights reserved
